Genomics

Dataset Information

0

In vivo G-CSF Treatment Activates GR-SOCS1 Axis Suppressing IFN-γ Secretion by Natural Killer Cells [CUT&TAG]


ABSTRACT: Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in controlling tumors or microbial infections through the production of interferon gamma (IFN-γ). Granulocyte-colony stimulating factor (G-CSF) inhibits IFN-γ secretion by NK cells, but the mechanism underlying this effect remains unclear. Here, by comparing the multi-omics profiles of human NK cells before and after in vivo G-CSF treatment, we identified a pathway that was activated in response to G-CSF treatment, which suppressed IFN-γ secretion in NK cells. Specifically, our integrative genomic strategy revealed glucocorticoid receptor (GR) activation in NK cells that mediated the genomic response to G-CSF treatment. Activated GRs can inhibit secretion of IFN-γ by promoting interactions between suppressor of cytokine signaling 1 (SOCS1) promoter and enhancer, as well as increase the expression of SOCS1. Experiments in mice confirmed that G-CSF in vivo treatment significantly down-regulated IFN-γ secretion and up-regulated GR and SOCS1 expression in NK cells. In addition, GR blockade (RU486) significantly reversed the effects of G-CSF, demonstrating that GR up-regulates SOCS1 and inhibits the production of IFN-γ by NK cells.

ORGANISM(S): Homo sapiens

PROVIDER: GSE205824 | GEO | 2022/09/14

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2022-09-14 | GSE205821 | GEO
2022-09-14 | GSE205823 | GEO
2022-09-14 | GSE205822 | GEO
2022-09-30 | GSE183866 | GEO
2014-06-01 | E-GEOD-47621 | biostudies-arrayexpress
2012-01-18 | E-GEOD-23508 | biostudies-arrayexpress
2012-01-18 | GSE23508 | GEO
2012-06-27 | E-GEOD-37012 | biostudies-arrayexpress
2023-09-25 | GSE243733 | GEO
2023-09-25 | GSE243732 | GEO